Quinoline derivatives as MELK inhibitors and their preparation and use in the treatment of cancer.

  • Matsuo Y
  • Hisada S
  • Nakamura Y
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

The invention directs a compd. represented by formula I that are useful as MELK inhibitors. Compds. of formula I wherein R1 is H, halo, CN, (un)substituted C3-10 cycloalkyl, etc.; R2 is H, halo, OH, (un)substituted aryl, etc.; R3 is H, halo, (un)substituted C1-6 alkyl, C1-6 alkoxy, etc.; R4 is H, halo, CN, etc.; R is H and halo; R101 is H and C1-6 alkyl; and pharmaceutically acceptable salts thereof, are claimed. Example compd. II was prepd. by a multistep procedure (procedure given). All the invention compds. were evaluated for their MELK inhibitory activity. From the assay, it was detd. that compd. II exhibited IC50 value of 0.021 μM. [on SciFinder(R)]

Cite

CITATION STYLE

APA

Matsuo, Y., Hisada, S., Nakamura, Y., Ahmed, F., Huntley, R., Walker, J. R., & Decornez, Helene. (2012, February 2). Quinoline derivatives as MELK inhibitors and their preparation and use in the treatment of cancer. PCT Int. Appl. Oncotherapy Science, Inc., Japan .

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free